Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 12.38% is 18% below its 5-year average of 15.15%, near the low end of its 5-year range (11.62%–19.09%).
0.89% above its 12-month average of 12.27%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 12.72%.
GROSS MARGIN
12.38%
GROSS MARGIN AVG TTM
12.27%
GROSS MARGIN AVG 3Y
13.47%
GROSS MARGIN AVG 5Y
15.15%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.89%
CURRENT VS 3Y AVG
-8.11%
CURRENT VS 5Y AVG
-18.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.12%
median of 393 covered companies
CURRENT VS SECTOR MEDIAN
-73.16%
vs the sector median at left
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Gross Margin
12.38%
TTM Avg
12.27%
3Y Avg
13.47%
5Y Avg
15.15%
Market Cap
$12.00B
Gross Margin
95.71%
TTM Avg
68.63%
3Y Avg
54.72%
5Y Avg
59.42%
Market Cap
$12.52B
Gross Margin
30.08%
TTM Avg
33.76%
3Y Avg
35.72%
5Y Avg
36.84%
Market Cap
$12.89B
Gross Margin
21.85%
TTM Avg
27.90%
3Y Avg
28.49%
5Y Avg
28.39%
Market Cap
$12.95B
Gross Margin
93.35%
TTM Avg
96.31%
3Y Avg
90.48%
5Y Avg
92.91%
Market Cap
$11.36B
Gross Margin
65.77%
TTM Avg
65.28%
3Y Avg
66.17%
5Y Avg
66.85%
Market Cap
$13.19B
Gross Margin
98.30%
TTM Avg
98.34%
3Y Avg
98.50%
5Y Avg
98.50%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 12.38% | 12.27% | 13.47% | 15.15% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 95.71% | 68.63% | 54.72% | 59.42% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 67.84% | 65.17% | 64.50% | 63.66% |
| Baxter International Inc. (BAX)vs › | $12.52B | 30.08% | 33.76% | 35.72% | 36.84% |
| DaVita Inc. (DVA)vs › | $11.47B | 31.02% | 29.95% | 30.17% | 30.48% |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 21.85% | 27.90% | 28.49% | 28.39% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | 93.35% | 96.31% | 90.48% | 92.91% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 65.77% | 65.28% | 66.17% | 66.85% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 98.30% | 98.34% | 98.50% | 98.50% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $11.12B | 75.55% | 78.40% | 77.70% | 76.19% |
Gross Margin
12.4%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 12.72% |
| 2026-03-31 | 13.34% |
| 2025-12-31 | 11.62% |
| 2025-09-30 | 11.76% |
| 2025-06-30 | 11.91% |
| 2025-03-31 | 11.76% |
| 2024-12-31 | 13.82% |
| 2024-09-30 | 14.04% |
| 2024-06-30 | 12.80% |
| 2024-03-31 | 12.80% |
| 2023-12-31 | 15.53% |
| 2023-09-30 | 15.88% |
| 2023-06-30 | 17.17% |
| 2023-03-31 | 16.50% |
| 2022-12-31 | 17.13% |
| 2022-09-30 | 16.94% |
| 2022-06-30 | 18.07% |
| 2022-03-31 | 18.07% |
| 2021-12-31 | 18.63% |
| 2021-09-30 | 18.53% |
| 2021-06-30 | 19.09% |
| 2021-03-31 | 18.28% |
| 2020-12-31 | 18.17% |
| 2020-09-30 | 19.13% |
| 2020-06-30 | 18.96% |
| 2020-03-31 | 18.96% |
| 2019-12-31 | 18.83% |
| 2019-09-30 | 18.98% |
| 2019-06-30 | 18.52% |
